Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure-Reference-Cited by-同舟云学术

Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

Published:2013-12-14 Issue:2 Volume:16 Page:143-150
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Iqbal Javaid¹,Parviz Yasir¹,Pitt Bertram²,Newell-Price John³,Al-Mohammad Abdallah¹,Zannad Faiez⁴

Affiliation:

1. Department of Cardiovascular Science at the University of Sheffield and Cardiology Department at Sheffield Teaching Hospitals NHS Trust; Sheffield UK

2. Cardiovascular Centre; University of Michigan; Ann Arbor MI USA

3. Department of Human Metabolism at the University of Sheffield and Endocrinology Department at Sheffield Teaching Hospitals NHS Trust; Sheffield UK

4. INSERM, Centre d'Investigation Clinique and Centre Hospitalier Universitaire, and the Department of Cardiology; Nancy University, Université de Lorraine; Nancy France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejhf.31/fullpdf

Reference66 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

3. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

4. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation;Jessup;Circulation,2009

5. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis;BMC Cardiovascular Disorders;2024-09-13

2. Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy;Drug Safety;2024-04-12

3. Steroidal MRA Across the Spectrum of Renal Function;JACC: Heart Failure;2022-11

4. Real world comparison of spironolactone and eplerenone in patients with heart failure;European Journal of Internal Medicine;2022-03

5. Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials;European Journal of Heart Failure;2020-02-19